Search results
Safe and Effective? The New York Times Revisits the COVID Jab. - The American Spectator | USA News...
American Spectator· 12 hours agoIt has taken three years, but the New York Times has finally admitted that maybe, just maybe, there are some serious side effects to COVID vaccines. AstraZeneca, which has ...
US opens COVID vaccine to little kids, shots begin next week
AOL· 5 days agoThe U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. The shots will...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoPfizer's Chief Development Officer Roger Dansey said in a statement. CAR-T drugs are developed using...
Why Pfizer Stock Blasted More Than 6% Higher Today
Motley Fool via Yahoo Finance· 3 days agoPfizer (NYSE: PFE) stock got a very effective shot in the arm on Wednesday. This was supplied by its latest earnings... Covid effect not as damaging as...
RFK Jr. repeats debunked vaccine claims in interview with Bill Maher
Salon via Yahoo News· 7 days agoKennedy then spouted a debunked claim that those who took the Pfizer vaccine in a clinical trial saw...
Pfizer Inc (PFE) Q1 2024 Earnings Call Transcript Highlights: Na
Guru Focus· 3 days agoTotal Revenue: $14.9 billion, operational decline of 19% year-over-year.Oncology Revenue: Grew 19% operationally, driven by acquisitions and product launches.A
The true tragedy of the Covid-19 vaccines
Daily Telegraph· 3 days agoIndeed, some public health officials exaggerated the benefits and underplayed some of the risks. Thrombosis caused by the AstraZeneca vaccine and...
GSK raises forecasts on strong vaccine, HIV drug sales
BioPharma Dive via Yahoo Finance· 3 days agoSales of the shingles vaccine Shingrix and the RSV shot Arexvy helped fuel quarterly revenue totals...
A Better Concept For mRNA Vaccines: Self-Amplification
Forbes· 5 days agoTwo new self-amplifying mRNA vaccines herald a new era of vaccination for coronaviruses.
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 2 days agovaccine in partnership with Merck. The shot prompts an immune response against a patient's own tumor...